Psychiatry Grand Rounds-16797-------4/11/2014, Votaw Auditorium
'Nerve Growth Factor for the Treatment of Depression, Anxiety and Craving'; John McMichael, Ph.D.
Dr. McMichael reports there IS relevant financial interest/arrangement of affiliation with one or more organizations which could be perceived as a real or apparent COI in the context
COI in the context of this presentation. Conflicts are: Beech Tree Labs, Milkhaus Laboratory. This presentation has been peer reviewed and found to be free of commercial bias.
This Continuing Medical Education activity has not received support from any commercial source.
How well did this activity meet the stated learning objectives?ExcellentAbove AverageAverageBelow AveragePoor
Understand the potential of NGF (Nerve Growth Factor) as a therapeutic agent          
Appreciate a novel mechanism of action and approach of treatment          
Please rate this presentation:ExcellentAbove AverageAverageBelow AveragePoor
Balanced, Objective, and Evidence Based          
Appropriate for intended audience          
Rate your level of knowledge BEFORE this educational activity          
Rate your level of knowledge AFTER this educational activity          
How well did this activity address a need you have in your practice          
Free of commercial bias    
Based on what you heard today:
Which physician attributes (core competencies) did the speaker incorporate into their presentation? Please choose all which apply:
Patient Care
Practice-Based Learning & Improvement
Medical Knowledge
System-Based Practice
Interpersonal & Communication Skills
How does NGF differ from SSRIs and tricyclics?
A). NGF up-and-down regulates different genes-- B). NGF is a naturally occurring regulatory molecule
C). Optimal concentrations of NGF appear to be considerably lower than those for most antidepressants-- D). All of the above-- E). None of the above
Correct answer is: D          
What new information/strategy do you plan to implement into your clinical practice?
What challenges or barriers might prevent you from implementing this new information/strategy?
What topics do you feel need to be addressed in future CME activities?
If you have questions, concerns, or comments about this activity, please contact: Barbara Sucher, M.B.A., Associate Dean for CME or 423.439.8081. Form Revised 4-2013